EMD-36727
Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state)
EMD-36727
Single-particle3.04 Å
Deposition: 03/07/2023Map released: 03/01/2024
Last modified: 15/01/2025
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: SARS-CoV-2 XBB1.5 spike glycoprotein with ACE2
Fitted models: 8jyn
Deposition Authors: Yajima H
,
Anraku Y ,
Kita S ,
Kimura K,
Sasaki J,
Sasaki-Tabata K,
Maenaka K,
Hashiguchi T
Sample: SARS-CoV-2 XBB1.5 spike glycoprotein with ACE2
Fitted models: 8jyn
Deposition Authors: Yajima H
,
Anraku Y ,
Kita S ,
Kimura K,
Sasaki J,
Sasaki-Tabata K,
Maenaka K,
Hashiguchi T
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tamura T ,
Irie T ,
Deguchi S,
Yajima H ,
Tsuda M ,
Nasser H ,
Mizuma K,
Plianchaisuk A ,
Suzuki S ,
Uriu K,
Begum MM,
Shimizu R,
Jonathan M ,
Suzuki R,
Kondo T ,
Ito H,
Kamiyama A,
Yoshimatsu K ,
Shofa M,
Hashimoto R ,
Anraku Y ,
Kimura KT ,
Kita S ,
Sasaki J,
Sasaki-Tabata K,
Maenaka K,
Nao N,
Wang L ,
Oda Y,
Ikeda T ,
Saito A ,
Matsuno K ,
Ito J ,
Tanaka S,
Sato K ,
Hashiguchi T ,
Takayama K ,
Fukuhara T
(2024) Nat Commun , 15 , 1176 - 1176
,
Irie T ,
Deguchi S,
Yajima H ,
Tsuda M ,
Nasser H ,
Mizuma K,
Plianchaisuk A ,
Suzuki S ,
Uriu K,
Begum MM,
Shimizu R,
Jonathan M ,
Suzuki R,
Kondo T ,
Ito H,
Kamiyama A,
Yoshimatsu K ,
Shofa M,
Hashimoto R ,
Anraku Y ,
Kimura KT ,
Kita S ,
Sasaki J,
Sasaki-Tabata K,
Maenaka K,
Nao N,
Wang L ,
Oda Y,
Ikeda T ,
Saito A ,
Matsuno K ,
Ito J ,
Tanaka S,
Sato K ,
Hashiguchi T ,
Takayama K ,
Fukuhara T
(2024) Nat Commun , 15 , 1176 - 1176
Grant Support:
- Japan Agency for Medical Research and Development (AMED): JP21am0101093 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP22ama121037 (Japan)
- Japan Science and Technology: JPMJCR20H8 (Japan)
- Japan Society for the Promotion of Science (JSPS): 20H05773 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP20H05873 (Japan)